Our test detects the three most common causes of infectious vaginitis–bacterial vaginosis, candida vaginitis and trichomoniasis—that make up to 95% of these cases. 1,2,3 While yeast infection or candida vaginitis (CV) is usually a result of overgrowth of candida albicans , it can also be caused by the azole-resistant strain candida glabrata ...

The Aptima® BV assay is an in vitro nucleic acid amplification test that utilizes real time transcription-mediated amplification (TMA) for detection and quantitation of ribosomal RNA from bacteria associated with bacterial vaginosis (BV), including Lactobacillus (L. gasseri, L.

CV and TV may be detected by microscopy, culture, and nucleic acid using specimens collected with vaginal swabs. The Aptima CV/TV assay is a real time TMA assay developed for use on the automated Panther system that detects and discriminates RNA markers from C …

Test with exceptional performance. Aptima® BV and Aptima® CV/TV assays are highly sensitive NAATs that deliver accurate diagnosis of vaginitis. Can pull up to 4 aliquots from specimen transfer tube. Detect up to 7 infections and disease states from just one vaginal swab.9-13 One-step, direct-load workflow on the automated Panther® system for

The Aptima ® BV and Aptima ® CV/TV assays are NAAT tests that identify bacterial vaginosis (BV), vulvovaginal candidiasis (Candida vaginitis or CV) and Trichomoniasis (Trichomonas vaginalis or TV) in symptomatic women from one vaginal sample.

2019年5月29日 · The Aptima ® Multitest Swab Specimen Collection Kit enables healthcare providers to test up to seven disease states and infections, including BV, Candida species, Candida glabrata, trichomoniasis, chlamydia, gonorrhea and Mycoplasma genitalium.

BV is the most common cause of vulvovaginitis in women ages 15-44, implicated in 40-50% of vaginitis cases. The prevalence in the United States is estimated to be 21.2 million (29.2%) among women ages 14-49. CV or VVC accounts for 20% to 25% of cases in the United States, while TV accounts for 15% to 20%.

2025年4月1日 · The FDA-approved BD Vaginal Panel and Aptima BV and Aptima CV/TV will replace the current laboratory developed tests for Bacterial Vaginosis and Candida. This change will improve turnaround time for Bacterial Vaginosis and Candida and streamline more of the Women’s Health test menu with the fully automated BD COR platform.

This assay is an in vitro nucleic acid amplification test that utilizes real time transcription-mediated amplification (TMA) for detection of organisms associated with bacterial vaginosis (BV), vulvovaginal candidiasis (CV) and trichomoniasis (TV).

Gain insights into your vaginal health with our At-Home Vaginitis Test. This comprehensive test covers the three most common causes of vaginitis: BV, CV, and TV. Ideal for diagnosing infections and managing symptoms from the comfort of your home.